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Noncommunicable diseases (NCD) are the leading causes of death and disability worldwide but have received
suboptimal attention and funding from the global health community. Although the first United Nations
General Assembly Special Session (UNGASS) for NCD in 2011 aimed to stimulate donor funding and
political action, only 1.3% of official development assistance for health was allocated to NCD in 2015,
even less than in 2011. In stark contrast, the UNGASS on human immunodeficiency virus and acquired
immune deficiency syndrome (HIV/AIDS) in 2001 sparked billions of dollars in funding for HIV and
enabled millions of HIV-infected individuals to access antiretroviral treatment. Using an existing analytic
framework, we compare the global responses to the HIV and NCD epidemics and distill lessons from the
HIV response that might be utilized to enhance the global NCD response. These include: 1) further
educating and empowering communities and patients to increase demand for NCD services and to hold
national governments accountable for establishing and achieving NCD targets; and 2) evidence to support
the feasibility and effectiveness of large-scale NCD screening and treatment programs in low-resource
settings. We conclude with a case study from Swaziland, a country that is making progress in confronting
both HIV and NCD.The authors report no
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j.gheart.2016.10.012In September 2011, the United Nations (UN)
convened a UN General Assembly Special Session
(UNGASS) on noncommunicable diseases (NCD). The
event was the second UN High Level Meeting ever held
for a health issue, following the successful UNGASS on
human immunodeficiency virus and acquired immune
deficiency syndrome (HIV/AIDS) in 2001. Modeled after
its predecessor, the 2011 meeting was intended to
catalyze a response to what the World Health Organi-
zation (WHO) called an epidemic of “silent killers” that
were the leading causes of death and disability world-
wide, yet receive little attention from the global health
community [1].
Looking back to the prior UNGASS on HIV/AIDS a
decade earlier, the NCD meeting aspired to similar goals:
rallying multisectoral and cross-national partnerships;
stimulating robust donor funding; spurring ambitious
targets and commitments on the part of national govern-
ments; and catalyzing rapid scale-up of NCD services in
resource-limited settings [2]. Advocates highlighted simi-
larities between chronic NCD and HIV/AIDS, including a
stark mismatch between the burden of disease and avail-
able funding, and the need for programmatic innovation,
continuity care, and health systems strengthening [3-5].
The UNGASS on NCD was successful at producing
a Political Declaration to combat NCD [6], and many
countries affirmed a commitment to ambitious NCD tar-
gets and to implementing evidence-based “best buys” [7,8].GLOBAL HEART, VOL. 11, NO. 4, 2016
December 2016: 403-408Yet 5 years later, the global NCD response has languished
in what some have called an environment of “malignant
neglect” [9]. Despite the fact that NCD account for 37% of
disability-adjusted life years in low-income countries [10],
only 1.3% of official development assistance for health was
allocated to NCD in 2015 [11], a proportion that decreased
between 2011 and 2015 [12]. Few resource-limited
countries have operational national NCD strategies or
adequate NCD services, awareness of and treatment-
seeking rates for NCD have not improved [13], and the
vast majority of people with cardiovascular disease, dia-
betes, cancer, and chronic respiratory disease remain un-
diagnosed and untreated [14,15]. In contrast, in the years
that followed the 2001 UNGASS, global spending on HIV
increased by billions of dollars and the number of people
initiating antiretroviral treatment (ART) in low- and
middle-income countries soared from 400,000 in 2003 to
nearly 17 million in 2015 [16].DIFFERING GLOBAL RESPONSES TO HIV AND NCD
The sluggish response to NCD despite the global consensus
and national commitments articulated at the UNGASS
meeting raises the question as to why some health issues
galvanize action while others fail to do so. Studies of the
comparative effectiveness of global health advocacy efforts
suggest that objective characteristics of health issues rarely
explain their success or failure in terms of attracting403
TABLE 1. Comparison of selected determinants of political priority setting from the early global responses to the HIV/AIDS and NCD
epidemics adapted from the Shiffman [17] framework
HIV/AIDS NCD
1) Ideas: the way the health challenge is understood and communicated
 HIV is a single disease and was a new and highly visible
health threat
 ART was widely understood to be highly effective—its impact
was described as “Lazarus-like,” returning people from the
brink of death. Disparities in access to ART were starkly
visible.
 HIV was framed as a threat to development and security, as it
visibly affected young, working-age people and destabilized
economies
 HIV is commonly framed as a humanitarian crisis by civil
society
 NCD are a collection of diseases, not perceived as novel
threats
 NCD treatment varies from condition to condition;
treatment effectiveness is also variable; therapeutic
nihilism about the feasibility of treatment for some NCD
is prevalent
 Incorrectly considered “diseases of the elderly” and
“diseases of the wealthy,” the NCD threat is poorly
recognized
 NCD are often perceived as a secondary issue to
infectious diseases, “a crisis for future generations”
2) Actor power: the strength of the individuals and organizations concerned with the issue
 Grassroots community activism led by those affected by HIV
arose to dispel stigma and AIDS denialism
 In 1996, Joint United Nations Programme on HIV/AIDS
formed as a dedicated UN branch to tackle the HIV/AIDS
epidemic, offering crucial central leadership and organizing
power
 Generally low awareness and demand from patients,
and low civil society involvement, especially in
low-resource settings where healthcare is organized
around HIV
 Multisectoral partnerships (e.g., NCD Alliance and
GACD in 2009) have organized to unite policy makers,
donors, researchers and civil society organizations;
WHO GCM/NCD was established in 2014 to coordinate
global efforts and improve accountability to NCD
targets
3) Political context: the environments in which actors connected with the issue operate
 In 1980s, dominantly conservative U.S. politics emphasized
personal responsibility and abstinence, effectively blaming
HIV-infected persons and stagnating HIV efforts
 HIV UNGASS occurred in the context of global economic
growth and increased funding scale and diversity
 Long-term financial commitments were demonstrated by the
Global Fund to fight AIDS, Tuberculosis and Malaria; PEPFAR;
and other international initiatives
 HIV, and other infectious diseases (e.g., malaria, tuberculosis)
were explicitly included in 2000 MDG targets
 NCD currently perceived as largely “diseases of
preventable individual behaviors,” placing responsibility
on populations affected
 NCD UNGASS occurred during global economic crisis,
with reduced funding availability
 To date, no large-scale dedicated funding commitment
for NCD akin to PEPFAR for AIDS
 NCD targets were omitted from MDGs but included in
SDGs in 2015
AIDS, acquired immune deficiency syndrome; ART, antiretroviral therapy; GACD, Global Alliance for Chronic Diseases; GCM/NCD, Global
Coordination Mechanism on NCDs; HIV, human immunodeficiency virus; MDG, Millennium Development Goals; NCD, noncommunicable disease;
PEPFAR, U.S. President’s Emergency Plan for AIDS Relief; SDG, Sustainable Development Goals; UN, United Nations; UNGASS, United Nations
General Assembly Special Session; WHO, World Health Organization.
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404attention, funding, and action [17]. Instead, as Shiffman
[17] observes, critical elements include the clarity and
cohesion of ideas used to define, describe, and frame the
issue; the strength and nature of the actors lobbying for
collective action; and political contexts that enhance lead-
ership support. The framework developed by Shiffman
provides useful insights into why some important health
issues fail to garner appropriate resources and attention. It
has been used to analyze the responses to maternal mor-
tality [18], maternal and child health [19,20], cervical
cancer [21], oral health [22], mental health [23], and NCD
[24]. In this paper, we use Shiffman’s framework to
contrast characteristics of HIV and NCD that may explainthe different global responses to the 2 entities and suggest
potential avenues for the path forward (Table 1).
Ideas: framing the problems
At the onset of the HIV epidemic, HIV was a new condition
never observed before, and it was lethal and frightening.
Affecting children, youth, and adults in their most pro-
ductive years, its devastating impact was evident to families
and communities, and its threat to the economies of
most severely affected countries was apparent to their
governments and to the global donor community [2]. The
development of effective treatment resulted in what has
been called the Lazarus effect, which transformed HIV intoGLOBAL HEART, VOL. 11, NO. 4, 2016
December 2016: 403-408
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a chronic disease for the few who could access treatment. It
also highlighted the glaring injustice of inequitable access
to treatment experienced by those living in poor countries
when contrasted with those in resource-rich settings. The
HIV epidemic was framed as both a humanitarian crisis
and a threat to economic development and security, mes-
sages which resonated with political leaders [25].
In contrast, NCD are not perceived as novel threats,
and are often incorrectly considered diseases of the elderly
or of the wealthy despite evidence to the contrary [26].
Although there is growing evidence of the cost effectiveness
of NCD prevention, screening, and management [27],
NCD are often perceived as costly to address, less impor-
tant than infectious diseases, and as a problem for future
generations rather than for immediate action [28]. These
misconceptions may be due to the chronicity of NCD, the
diversity of prevention, care and treatment interventions,
and the fact that many disparate conditions are grouped
under a single label [29]. The sheer numbers of people
living with NCD may also result in therapeutic nihilism
about the feasibility of treatment. Last, the diversity of
NCD and of individuals affected has contributed to frag-
mented civil society activism. These characteristics make
communication and education about NCD challenging,
leading to misperceptions that have been difficult to dispel
(Table 1).Actor power: networks and advocates
In many resource-rich countries, men who have sex with
men (MSM) were disproportionately affected in the early
years of the HIV epidemic. The MSM community, politi-
cized by its struggles for civil rights, was positioned to rise
to combat the stigma and AIDS denialism rampant at the
time, and to fight for access to prevention, care, and
treatment [30,31]. A strong grassroots movement arose out
of necessity to provide care and support for people living
with HIV/AIDS (PLWH), dispel HIV myths and stigma,
and advocate for funding of HIV programs and research.
By the early 2000s, solidarity among communities affected
by HIV empowered advocates to fight for an augmented
HIV response around the world, particularly in resource-
constrained settings. Over the ensuing decade, the suc-
cess of large-scale HIV programs in low-resource settings
provided crucial evidence of the feasibility and impact of
scaling up HIV treatment, further increasing pressure on
policy makers and donors to maintain and build on this
momentum [32].
In contrast, the diverse communities affected by NCD
have been less successful at creating a cohesive voice, and
consequently have had limited impact on expanding ac-
cess to NCD services, despite evidence showing that the
engagement of civil society in advocacy, accountability,
and NCD service provision can catalyze national action
[33]. Multisectoral partnerships including the NCD Alli-
ance, the Global Alliance for Chronic Diseases, and the
WHO Global Coordination Mechanism on NCD (GCM/GLOBAL HEART, VOL. 11, NO. 4, 2016
December 2016: 403-408NCD) have formed to support civil society groups and to
improve coordination between multisectoral stakeholders.
However, these groups coexist with disease-specific ini-
tiatives, such as the International Diabetes Foundation, the
International Union Against Tuberculosis and Lung Dis-
eases, the World Heart Federation, and the Union for
International Cancer Control, creating a complex advocacy
environment. The necessity of separate, parallel efforts for
different diseases impedes the WHO GCM/NCD from
providing the level of central leadership and organizing
power for all NCD, as offered by the Joint UN Programme
on HIV/AIDS for HIV initiatives (Table 1).
Political contexts and policy environments
Although the 2001 UNGASS on HIV took place at a time
of increasing global health funding and a growing num-
ber and diversity of global health donors, the 2011
UNGASS on NCD occurred in the midst of a global
economic crisis, which limited opportunities for new
funding. NCD were also disadvantaged by their omission
from the 2000 Millennium Development Goals [34,35].
The HIV response was enabled by the establishment of
the Global Fund to Fight AIDS, Tuberculosis and Malaria
in 2002, and by unique political partnerships in the
United States that created the PEPFAR (U.S. President’s
Emergency Plan for AIDS Relief) in 2004. To date, no
analogous funding initiatives exist for NCD. The inclu-
sion of NCD in the Sustainable Development Goals is
noted as a policy victory, but has yet to be matched with
an increase in funding commitments [36].
LEVERAGING THE LESSONS OF HIV
The emergency response to HIV was not without its limi-
tations, but the scale-up of HIV services is credited with
preventing 30 million new HIV infections, saving
7.8 million lives, averting 9 million orphans, and trans-
forming global health more broadly [37]. The Shiffman
framework suggests that although some variables that
contribute to successful global networks may be unmodifi-
able (e.g., global political context), attention to NCD mes-
sage framing and actor networks are critically important.
In terms of actor networks, lessons from the HIV
response suggest that multisectoral advocacy and outreach
to inform communities can increase demand for NCD
services and spur action on the part of health providers as
well as political leaders. Alignment of NCD activism with
global goals—whether in relation to the Sustainable
Development Goals or the current movement for Universal
Health Coverage—may increase pressure on national
governments to reach targets. Another important resource
may be PLWH, now living longer on ART and confronting
the same NCD risks as other members of their families and
communities without HIV infection [38,39].
In terms of ideas and message framing, a missing
element for global mobilization may be the lack of evidence
of the feasibility, acceptability, impact, and cost405
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programs. The NCD community has a remarkable oppor-
tunity to garner the programmatic lessons learned from the
successful HIV response on how to design, deliver, scale
up, and evaluate continuity care services in resource-
limited settings; these same chronic care platforms could
also be leveraged to provide NCD services to PLWH or to
the general population [5,40-43]. The successful integra-
tion of NCD services within HIV programs could provide
both proof of concept for large-scale NCD screening,
diagnosis, and management services and a portfolio of
programmatic strategies and tools that can be adopted for
the general population [44].
SWAZILAND: A CASE STUDY
The Kingdom of Swaziland faces the world’s most severe
HIV epidemic, with an estimated HIV prevalence of 31%
among adults [45]. Over the past decade, the government
has scaled up HIV treatment with funding support from
the PEPFAR and The Global Fund. The Swaziland Min-
istry of Health (MOH) and the Swaziland National AIDS
Program have rapidly expanded and decentralized HIV
treatment services and approximately 70% of the coun-
try’s estimated 222,102 PLWH have initiated ART [46].
As a result, annual mortality from HIV has decreased by
35% in under a decade [47].
As in other countries, NCD had not captured the
attention of Swaziland’s public health experts, largely due
to the severity of other health threats such as HIV and
tuberculosis. However, a recent population survey found a
high prevalence of NCD and their risk factors among adults
15 to 69 years of age [48]. One in 5 of those surveyed were
obese, an additional 23.4% were overweight, and 24.5%
had elevated blood pressure [48]. Overall, 8.7% of the
population had either existing cardiovascular disease or
>30% 10-year risk of a cardiovascular event. Surveillance
data suggest that NCD already account for 24% of annual
deaths nationally [49]. Many of these deaths could be
prevented with early diagnosis and appropriate
management.
Recognizing the potential to leverage the HIV plat-
form to enhance NCD services, the MOH is taking 2 key
steps: 1) integrating screening, treatment, and referral for
diabetes, hypertension, and cervical cancer into HIV
programs; and 2) adapting the chronic care models
originally developed for HIV for use in NCD management
for the general population. In 2014, the MOH launched a
national NCD strategic plan and convened an NCD
Technical Working Group to guide these activities moving
forward.
HIV-NCD integration
The NCD strategic plan in Swaziland prioritized integration
of HIV and NCD services to diagnose and treat NCD
among persons living with HIV. HIV provider training is
being expanded to include training on integrated clinicalmanagement of HIV and NCD, and clinical practice
guidelines have been developed for NCD such as diabetes,
hypertension, dyslipidemia, cerebrovascular accidents, and
chronic obstructive pulmonary disease. High-volume HIV
clinics were also equipped to conduct cervical cancer
screening and management using visual inspection with
acetic acid, cryotherapy, and palliative care, as needed.
NCD-related indicators have been incorporated into the
country’s electronic HIV medical records systems, which
are currently being rolled out. Once implemented at scale,
this will enhance long-term follow-up for chronic NCD
care, as well as routine program monitoring and evaluation
of integrated HIV and NCD services.Swaziland’s national NCD program
The MOH has also adapted previously HIV-specific sys-
tems and tools for non-HIV settings. Several resources
developed for the HIV/NCD integration initiative have
been adopted for use in the general population, including a
locally adapted screening tool for depression; monitoring,
and evaluation systems and tools; the NCD clinical practice
guidelines; and clinical mentorship strategies. HIV-infected
women were initially prioritized for cervical cancer
screening and treatment services, but this has evolved with
services now being made available to all women, irre-
spective of HIV serostatus.
The national NCD program is also replicating the
public health approach that has been the cornerstone of
HIV scale-up. The expansion of HIV treatment was enabled
by decentralization of HIV care and treatment services to
lower-level facilities, task shifting to enable nurses to
manage HIV-infected patients, and the training of com-
munity health workers and peer educators to serve hard-
to-reach populations [50]. Building on this success, the
same approach is now being used to facilitate the scale-up
of services for NCD. At the policy level, the Tobacco
Products Control Act passed in 2013 has provided a legal
framework to regulate illicit tobacco sales and prevent ac-
cess to minors, in accordance with the country’s commit-
ment to the WHO Framework Convention on Tobacco
Control [51].
Last, consistent with the grassroots engagement that
epitomized the HIV response, civil society organizations
are playing an increased role in the NCD response in
Swaziland. For example, Diabetes Swaziland, a nonprofit
organization, has trained 120 community caregivers to
provide home-based diabetes care and 100 diabetes peer
educators. Swaziland Cancer Survivors and Caregivers
conducts community education programs to promote
healthy lifestyles, empower the community to recognize
early signs and symptoms and seek care for NCD, and
increase awareness and demand for NCD screening and
care. The Swaziland Breast and Cervical Cancer Network is
a nongovernmental organization that supports health
worker training and the procurement of equipment
necessary to screen and treat cervical cancer.GLOBAL HEART, VOL. 11, NO. 4, 2016
December 2016: 403-408
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Despite these promising initiatives, there are important
barriers to the further scale-up of NCD services in the
country. Although these initiatives move toward national-
level NCD service provision, they remain disease-specific,
and further efforts will be required to achieve coordi-
nated comprehensive care for NCD. The most critical issue
is the lack of funding for NCD-specific programs, as
leveraging the HIV platform can only go so far. Demon-
strating the feasibility, affordability, and impact of large-
scale NCD screening and treatment programs will be an
important step toward advocating for additional funding.
In addition, pursuing the implementation science agenda
should be considered a priority for MOH and civil society
organizations as this will help inform the design and
implementation of such programs.
SUMMARY
Despite increasing attention to the global NCD crisis,
funding for NCD programs in resource-limited settings has
been scarce. To augment the NCD response, it may be
prudent to understand the framing and networking stra-
tegies employed by those engaged in the HIV response.
Leveraging lessons from the scale-up of HIV treatment as
well as the chronic care platforms developed for the
management of HIV may also serve to catapult the NCD
response. Identifying synergies between HIV and NCD
programs, and aligning both with the movement towards
universal health coverage, may also be effective to enable
securing of the necessary resources and political will, and
ultimately overcoming the current prevailing inertia of
policy makers and donors.
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